HER-2 status of the primary breast cancer in patients with late disease relapse

被引：0
|
作者：
Tomasevic, Zorica [1 ]
Jovanovic, Danica [1 ]
Radosevic-Jelic, Ljiljana [1 ]
Tomasevic, Zoran [1 ]
Vasovic, Suzana [1 ]
Stamatovic, Ljiljana [1 ]
Jelic, Svetislav [1 ]
Spasic, Jelena [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Belgrade, Serbia
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [31] Comparative assays for the HER-2/neu oncogene status in breast cancer
    Vera-Román, JM
    Rubio-Martínez, LA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2004, 128 (06) : 627 - 633
  • [32] Evaluation of Serum HER-2/neu Extracelluar Domain in Breast Cancer Patients: Correlation with Tissue HER-2/neu Status and Clinicopathological Factors
    Kang, Sun Hee
    Cho, Jihyoung
    Ha, Jung Sook
    Kwon, Sun Young
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2010, 78 (05): : 271 - 276
  • [33] Status of estrogen, progesterone and her-2/neu receptors in breast cancer
    Lumturije, G.
    Kushtrim, S. H.
    Rame, A.
    Adriatik, K.
    Esat, B.
    Ardita, K.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 87 - 87
  • [34] Prognostic significance of HER-2 status in women with inflammatory breast cancer
    Dawood, Shaheenah
    Broglio, Kristine
    Gong, Yun
    Yang, Wei-Tse
    Cristofanilli, Massimo
    Kau, Shu-Wan
    Meric-BernstaM, Funda
    Buchholz, Thomas A.
    Hortobagyi, Gabriel N.
    Gonzalez-Angulo, Ana M.
    CANCER, 2008, 112 (09) : 1905 - 1911
  • [35] The association of HER-2 status with disease outcome in premenopausal early breast cancer patients treated with adjuvant ovarian ablation
    Susnjar, S.
    Vujasinovic, T.
    Abu Rabi, Z.
    Gavrilovic, D.
    Neskovic-Konstantinovic, Z.
    Jovanovic, D.
    Borojevic, N.
    EJC SUPPLEMENTS, 2008, 6 (07): : 123 - 123
  • [36] Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature
    Arslan, Cagatay
    Sari, Ebru
    Aksoy, Sercan
    Altundag, Kadri
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (01) : 21 - 30
  • [37] Comparison of fluorescence in situ hybridization and immunohistochemistry for assessment of HER-2 status in breast cancer patients
    Lin Wang
    Xiaobei Wang
    Xiu Nie
    Ling Ma
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29 : 354 - 358
  • [38] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    Wang, Lin
    Wang, Xiaobei
    Nie, Xiu
    Ma, Ling
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2009, 29 (03) : 354 - 358
  • [39] Comparison of Fluorescence in situ Hybridization and Immunohistochemistry for Assessment of HER-2 Status in Breast Cancer Patients
    王琳
    王晓蓓
    聂秀
    马玲
    Current Medical Science, 2009, 29 (03) : 354 - 358
  • [40] HER-2/neu Status: A Neglected Marker of Prognostication and Management of Breast Cancer Patients in India
    Zubeda, Syeda
    Kaipa, Prabhakar Rao
    Shaik, Noor Ahmad
    Mohiuddin, Mohammed Khaliq
    Vaidya, Sireesha
    Pavani, Boddana
    Srinivasulu, Mukta
    Latha, Manolla Madhavi
    Hasan, Qurratulain
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (04) : 2231 - 2235
12345